192 GENES FOUND

? »

Limit search: Premium | Premium (Subcell) | Premium (Cell line)

Page of 4 | next »

Show / hide columns »

XML | RDF | TAB

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Subcell

Cell line

Cancer

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

AASSAminoadipate-semialdehyde synthaseDisease related genes
Enzymes
Mitochondrial proteins
Potential drug targets
Mixed
ACADMAcyl-CoA dehydrogenase, C-4 to C-12 straight chainDisease related genes
Enzymes
Mitochondrial proteins
Potential drug targets
Expressed in all
ACADSAcyl-CoA dehydrogenase, C-2 to C-3 short chainDisease related genes
Enzymes
Mitochondrial proteins
Plasma proteins
Potential drug targets
Expressed in all
ACADVLAcyl-CoA dehydrogenase, very long chainDisease related genes
Enzymes
Mitochondrial proteins
Potential drug targets
Expressed in all
ACOX1Acyl-CoA oxidase 1, palmitoylDisease related genes
Enzymes
Potential drug targets
Expressed in all
ACOX2Acyl-CoA oxidase 2, branched chainEnzymes
Tissue enhanced
ADH1AAlcohol dehydrogenase 1A (class I), alpha polypeptideEnzymes
FDA approved drug targets
Plasma proteins
Tissue enriched
ADH1BAlcohol dehydrogenase 1B (class I), beta polypeptideEnzymes
FDA approved drug targets
Plasma proteins
Group enriched
ADH4Alcohol dehydrogenase 4 (class II), pi polypeptideEnzymes
Plasma proteins
Tissue enriched
ADH5Alcohol dehydrogenase 5 (class III), chi polypeptideEnzymes
Plasma proteins
Expressed in all
ADH7Alcohol dehydrogenase 7 (class IV), mu or sigma polypeptideEnzymes
Tissue enriched
ADO2-aminoethanethiol (cysteamine) dioxygenaseEnzymes
Expressed in all
AKR1B1Aldo-keto reductase family 1, member B1 (aldose reductase)Cancer-related genes
Enzymes
Plasma proteins
Tissue enriched
AKR1C2Aldo-keto reductase family 1, member C2Disease related genes
Enzymes
FDA approved drug targets
Tissue enhanced
AKR1D1Aldo-keto reductase family 1, member D1Disease related genes
Enzymes
FDA approved drug targets
Tissue enriched
AKR7A2Aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)Enzymes
Plasma proteins
Expressed in all
ALDH18A1Aldehyde dehydrogenase 18 family, member A1Disease related genes
Enzymes
Mitochondrial proteins
Plasma proteins
Potential drug targets
Expressed in all
ALDH1A1Aldehyde dehydrogenase 1 family, member A1Enzymes
Plasma proteins
Expressed in all
ALDH1L1Aldehyde dehydrogenase 1 family, member L1Enzymes
Plasma proteins
Tissue enhanced
ALDH3A1Aldehyde dehydrogenase 3 family, member A1Enzymes
Tissue enhanced
ALDH3B1Aldehyde dehydrogenase 3 family, member B1Enzymes
Mixed
ALDH4A1Aldehyde dehydrogenase 4 family, member A1Disease related genes
Enzymes
Mitochondrial proteins
Plasma proteins
Potential drug targets
Expressed in all
ALDH5A1Aldehyde dehydrogenase 5 family, member A1Disease related genes
Enzymes
Mitochondrial proteins
Potential drug targets
Expressed in all
ALDH6A1Aldehyde dehydrogenase 6 family, member A1Disease related genes
Enzymes
Mitochondrial proteins
Potential drug targets
Predicted membrane proteins
Group enriched
ALDH9A1Aldehyde dehydrogenase 9 family, member A1Enzymes
Plasma proteins
Predicted secreted proteins
Expressed in all
ALKBH1AlkB, alkylation repair homolog 1 (E. coli)Enzymes
Plasma proteins
Predicted secreted proteins
Expressed in all
ALKBH2AlkB, alkylation repair homolog 2 (E. coli)Enzymes
Expressed in all
ALOX12Arachidonate 12-lipoxygenaseDisease related genes
Enzymes
Potential drug targets
Group enriched
ALOX5Arachidonate 5-lipoxygenaseEnzymes
FDA approved drug targets
Tissue enhanced
AOC1Amine oxidase, copper containing 1Enzymes
Predicted secreted proteins
Group enriched
AOC3Amine oxidase, copper containing 3Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhanced
AOX1Aldehyde oxidase 1Enzymes
Plasma proteins
Tissue enhanced
ASPHAspartate beta-hydroxylaseCancer-related genes
Enzymes
Plasma proteins
Predicted membrane proteins
Expressed in all
BBOX1Butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1Enzymes
Tissue enhanced
BCKDHBBranched chain keto acid dehydrogenase E1, beta polypeptideDisease related genes
Enzymes
Mitochondrial proteins
Potential drug targets
Predicted secreted proteins
Expressed in all
BDH13-hydroxybutyrate dehydrogenase, type 1Candidate cardiovascular disease genes
Enzymes
Mitochondrial proteins
Expressed in all
BDH23-hydroxybutyrate dehydrogenase, type 2Enzymes
Predicted secreted proteins
Expressed in all
BLVRBBiliverdin reductase B (flavin reductase (NADPH))Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Expressed in all
CATCatalaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
CBR1Carbonyl reductase 1Enzymes
Plasma proteins
Expressed in all
CDO1Cysteine dioxygenase type 1Enzymes
Tissue enhanced
CHDHCholine dehydrogenaseEnzymes
Mitochondrial proteins
Tissue enhanced
CPCeruloplasmin (ferroxidase)Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted secreted proteins
Tissue enriched
CRYL1Crystallin, lambda 1Enzymes
Plasma proteins
Expressed in all
CRYZCrystallin, zeta (quinone reductase)Enzymes
Plasma proteins
Expressed in all
CYB5R1Cytochrome b5 reductase 1Enzymes
Expressed in all
CYB5R3Cytochrome b5 reductase 3Cancer-related genes
Disease related genes
Enzymes
Mitochondrial proteins
Potential drug targets
Predicted membrane proteins
Expressed in all
CYP11A1Cytochrome P450, family 11, subfamily A, polypeptide 1Disease related genes
Enzymes
Mitochondrial proteins
Potential drug targets
Group enriched
CYP11B1Cytochrome P450, family 11, subfamily B, polypeptide 1Disease related genes
Enzymes
FDA approved drug targets
Mitochondrial proteins
Tissue enriched
CYP11B2Cytochrome P450, family 11, subfamily B, polypeptide 2Disease related genes
Enzymes
Mitochondrial proteins
Potential drug targets
Tissue enriched

Page of 4 | next »